このアイテムのアクセス数: 367
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
36_0741.pdf | 299.31 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 打林, 忠雄 | ja |
dc.contributor.author | 長野, 賢一 | ja |
dc.contributor.author | 久住, 治男 | ja |
dc.contributor.author | 沢木, 勝 | ja |
dc.contributor.author | 川口, 光平 | ja |
dc.contributor.author | 小松, 和人 | ja |
dc.contributor.author | 小泉, 久志 | ja |
dc.contributor.author | 三崎, 俊光 | ja |
dc.contributor.author | 中島, 慎一 | ja |
dc.contributor.author | 折戸, 松男 | ja |
dc.contributor.author | 庄田, 良中 | ja |
dc.contributor.author | 山口, 一洋 | ja |
dc.contributor.author | 小橋, 一功 | ja |
dc.contributor.author | 菅田, 敏明 | ja |
dc.contributor.author | 橋本, 和夫 | ja |
dc.contributor.author | 松林, 久一 | ja |
dc.contributor.alternative | Uchibayashi, Tadao | en |
dc.contributor.alternative | Nagano, Kenichi | en |
dc.contributor.alternative | Hisazumi, Haruo | en |
dc.contributor.alternative | Sawaki, Masaru | en |
dc.contributor.alternative | Kawaguchi, Kohei | en |
dc.contributor.alternative | Komatsu, Kazuto | en |
dc.contributor.alternative | Koizumi, Hisashi | en |
dc.contributor.alternative | Misaki, Toshimitsu | en |
dc.contributor.alternative | Nakashima, Shinichi | en |
dc.contributor.alternative | Orito, Matsuo | en |
dc.contributor.alternative | Shoda, Ryochu | en |
dc.contributor.alternative | Yamaguchi, Kazuyo | en |
dc.contributor.alternative | Kobashi, Kazunori | en |
dc.contributor.alternative | Sugata, Toshiaki | en |
dc.contributor.alternative | Hashimoto, Kazuo | en |
dc.contributor.alternative | Matsubayashi, Kyuichi | en |
dc.date.accessioned | 2010-06-01T02:14:28Z | - |
dc.date.available | 2010-06-01T02:14:28Z | - |
dc.date.issued | 1990-06 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/116914 | - |
dc.description.abstract | Diffusion of ofloxacin (OFLX) into prostatic tissue was studied in 31 patients with benign prostatic hypertrophy. Concentrations of OFLX in the serum and prostatic tissue were measured at scheduled intervals after 200 mg OFLX oral administration. The mean OFLX level in prostatic tissue and tissue/serum ratio at 2 hours, 4 hours and 6 hours was 3.33 +/- 0.96 micrograms/g (1.25 +/- 0.28) in 10 patients, 2.21 +/- 0.55 micrograms/g (0.92 +/- 0.32) in 9 patients and 2.10 +/- 0.99 micrograms/g (1.01 +/- 0.23) in 12 patients, respectively. OFLX levels in prostatic tissue covered the minimum inhibitory concentration for several pathogenic bacteria detected from the infected prostatic fluid. Therefore, OFLX was thought to be a very useful drug for the treatment of bacterial prostatitis and postoperative infection of prostatic surgery. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.subject | Administration, Oral | en |
dc.subject | Aged | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Ofloxacin/administration & dosage/blood/pharmacokinetics | en |
dc.subject | Prostate/metabolism | en |
dc.subject | Prostatic Hyperplasia/metabolism | en |
dc.subject.ndc | 494.9 | - |
dc.title | Ofloxacin(OFLX)の前立腺組織内移行に関する検討 | ja |
dc.title.alternative | Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 36 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 741 | - |
dc.identifier.epage | 745 | - |
dc.textversion | publisher | - |
dc.sortkey | 20 | - |
dc.address | 金沢大学医学部泌尿器科学教室 | ja |
dc.address | 富山労災病院泌尿器科 | ja |
dc.address | 能登総合病院泌尿器科 | ja |
dc.address | 黒部市民病院泌尿器科 | ja |
dc.address | 市立砺波総合病院泌尿器科 | ja |
dc.address | 鳴和総合病院泌尿器科 | ja |
dc.address | 北陸病院泌尿器科 | ja |
dc.address | 辰口芳珠記念病院泌尿器科 | ja |
dc.address | 公立加賀中央病院泌尿器科 | ja |
dc.address | 福井済生会病院泌尿器科 | ja |
dc.address | 金沢大学医学部衛生学教室 | ja |
dc.address | 第一製薬株式会社中央研究所 | ja |
dc.address.alternative | The Department of Urology, School of Medicine, Kanazawa University | en |
dc.address.alternative | The Department of Urology, Toyama Rohsai Hospital | en |
dc.address.alternative | The Department of Urology, Noto General Hospital | en |
dc.address.alternative | The Department of Urology, Kurobe Citizen Hospital | en |
dc.address.alternative | The Department of Urology, Tonami General Hospital | en |
dc.address.alternative | The Department of Urology, Naruwa General Hospita | en |
dc.address.alternative | The Department of Urology, Hokuriku Hospital | en |
dc.address.alternative | The Department of Urology, Kaga Central Hospital | en |
dc.address.alternative | The Department of Urology, Fukui Saiseikai Hospital | en |
dc.address.alternative | The Department of Hygienics, School of Medicine, Kanazawa University | en |
dc.address.alternative | The Research Institute, Daiichi Pharmaceutical Co. LTD. | en |
dc.identifier.pmid | 1700587 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.36 No.6 |

このリポジトリに保管されているアイテムはすべて著作権により保護されています。